Matches in SemOpenAlex for { <https://semopenalex.org/work/W1452946734> ?p ?o ?g. }
- W1452946734 endingPage "308.e2" @default.
- W1452946734 startingPage "301" @default.
- W1452946734 abstract "Background & AimsNonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in the United States. However, few data are available on recent trends in the incidence and prevalence of NAFLD in the U.S.MethodsWe analyzed the national Veterans Administration databases from 2003 to 2011 and calculated the age-adjusted prevalence and incidence of NAFLD for the overall sample of patients and by demographic subgroups. We used a previously validated algorithm to define NAFLD, which was based on persistent increases in levels of liver enzymes in the absence of positive results from tests for hepatitis C or hepatitis B or evidence of excessive alcohol use.ResultsOf the 9,784,541 patients with at least 1 visit to the Veterans Administration between 2003 and 2011, 1,330,600 patients (13.6%) had NAFLD. The annual incidence rates of NAFLD remained stable (from 2.2% to 3.2%) during the study duration. The prevalence of NAFLD increased from 6.3% in 2003 (95% confidence interval, 6.26%–6.3%) to 17.6% in 2011 (95% confidence interval, 17.58%–17.65%), a 2.8-fold increase. The incidence and prevalence increased at significantly greater rates in patients younger than 45 years vs older patients.ConclusionsIn a U.S. population, the annual incidence of NAFLD ranges from 2% to 3%. The prevalence of NAFLD more than doubled from 2003 through 2011; it is likely to continue to increase because of a steady overall incidence coupled with a rising incidence in younger individuals. Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in the United States. However, few data are available on recent trends in the incidence and prevalence of NAFLD in the U.S. We analyzed the national Veterans Administration databases from 2003 to 2011 and calculated the age-adjusted prevalence and incidence of NAFLD for the overall sample of patients and by demographic subgroups. We used a previously validated algorithm to define NAFLD, which was based on persistent increases in levels of liver enzymes in the absence of positive results from tests for hepatitis C or hepatitis B or evidence of excessive alcohol use. Of the 9,784,541 patients with at least 1 visit to the Veterans Administration between 2003 and 2011, 1,330,600 patients (13.6%) had NAFLD. The annual incidence rates of NAFLD remained stable (from 2.2% to 3.2%) during the study duration. The prevalence of NAFLD increased from 6.3% in 2003 (95% confidence interval, 6.26%–6.3%) to 17.6% in 2011 (95% confidence interval, 17.58%–17.65%), a 2.8-fold increase. The incidence and prevalence increased at significantly greater rates in patients younger than 45 years vs older patients. In a U.S. population, the annual incidence of NAFLD ranges from 2% to 3%. The prevalence of NAFLD more than doubled from 2003 through 2011; it is likely to continue to increase because of a steady overall incidence coupled with a rising incidence in younger individuals." @default.
- W1452946734 created "2016-06-24" @default.
- W1452946734 creator A5027343826 @default.
- W1452946734 creator A5027832933 @default.
- W1452946734 creator A5075525513 @default.
- W1452946734 creator A5077205077 @default.
- W1452946734 creator A5082326728 @default.
- W1452946734 creator A5086965411 @default.
- W1452946734 date "2016-02-01" @default.
- W1452946734 modified "2023-10-18" @default.
- W1452946734 title "Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans" @default.
- W1452946734 cites W1622799587 @default.
- W1452946734 cites W1966454708 @default.
- W1452946734 cites W1975701178 @default.
- W1452946734 cites W1983354183 @default.
- W1452946734 cites W2002360949 @default.
- W1452946734 cites W2033136851 @default.
- W1452946734 cites W2048770210 @default.
- W1452946734 cites W2059251195 @default.
- W1452946734 cites W2059630954 @default.
- W1452946734 cites W2066019849 @default.
- W1452946734 cites W2077618811 @default.
- W1452946734 cites W2089497956 @default.
- W1452946734 cites W2098555833 @default.
- W1452946734 cites W2112496618 @default.
- W1452946734 cites W2136795008 @default.
- W1452946734 cites W2151106782 @default.
- W1452946734 cites W2151172917 @default.
- W1452946734 cites W2162365687 @default.
- W1452946734 cites W2172137144 @default.
- W1452946734 doi "https://doi.org/10.1016/j.cgh.2015.08.010" @default.
- W1452946734 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4918764" @default.
- W1452946734 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26291667" @default.
- W1452946734 hasPublicationYear "2016" @default.
- W1452946734 type Work @default.
- W1452946734 sameAs 1452946734 @default.
- W1452946734 citedByCount "125" @default.
- W1452946734 countsByYear W14529467342016 @default.
- W1452946734 countsByYear W14529467342017 @default.
- W1452946734 countsByYear W14529467342018 @default.
- W1452946734 countsByYear W14529467342019 @default.
- W1452946734 countsByYear W14529467342020 @default.
- W1452946734 countsByYear W14529467342021 @default.
- W1452946734 countsByYear W14529467342022 @default.
- W1452946734 countsByYear W14529467342023 @default.
- W1452946734 crossrefType "journal-article" @default.
- W1452946734 hasAuthorship W1452946734A5027343826 @default.
- W1452946734 hasAuthorship W1452946734A5027832933 @default.
- W1452946734 hasAuthorship W1452946734A5075525513 @default.
- W1452946734 hasAuthorship W1452946734A5077205077 @default.
- W1452946734 hasAuthorship W1452946734A5082326728 @default.
- W1452946734 hasAuthorship W1452946734A5086965411 @default.
- W1452946734 hasBestOaLocation W14529467342 @default.
- W1452946734 hasConcept C120665830 @default.
- W1452946734 hasConcept C121332964 @default.
- W1452946734 hasConcept C126322002 @default.
- W1452946734 hasConcept C2776455275 @default.
- W1452946734 hasConcept C2776954865 @default.
- W1452946734 hasConcept C2777075537 @default.
- W1452946734 hasConcept C2777214474 @default.
- W1452946734 hasConcept C2778772119 @default.
- W1452946734 hasConcept C2779102576 @default.
- W1452946734 hasConcept C2779134260 @default.
- W1452946734 hasConcept C2908647359 @default.
- W1452946734 hasConcept C44249647 @default.
- W1452946734 hasConcept C61511704 @default.
- W1452946734 hasConcept C71924100 @default.
- W1452946734 hasConcept C72563966 @default.
- W1452946734 hasConcept C88879693 @default.
- W1452946734 hasConcept C90924648 @default.
- W1452946734 hasConcept C99454951 @default.
- W1452946734 hasConceptScore W1452946734C120665830 @default.
- W1452946734 hasConceptScore W1452946734C121332964 @default.
- W1452946734 hasConceptScore W1452946734C126322002 @default.
- W1452946734 hasConceptScore W1452946734C2776455275 @default.
- W1452946734 hasConceptScore W1452946734C2776954865 @default.
- W1452946734 hasConceptScore W1452946734C2777075537 @default.
- W1452946734 hasConceptScore W1452946734C2777214474 @default.
- W1452946734 hasConceptScore W1452946734C2778772119 @default.
- W1452946734 hasConceptScore W1452946734C2779102576 @default.
- W1452946734 hasConceptScore W1452946734C2779134260 @default.
- W1452946734 hasConceptScore W1452946734C2908647359 @default.
- W1452946734 hasConceptScore W1452946734C44249647 @default.
- W1452946734 hasConceptScore W1452946734C61511704 @default.
- W1452946734 hasConceptScore W1452946734C71924100 @default.
- W1452946734 hasConceptScore W1452946734C72563966 @default.
- W1452946734 hasConceptScore W1452946734C88879693 @default.
- W1452946734 hasConceptScore W1452946734C90924648 @default.
- W1452946734 hasConceptScore W1452946734C99454951 @default.
- W1452946734 hasIssue "2" @default.
- W1452946734 hasLocation W14529467341 @default.
- W1452946734 hasLocation W14529467342 @default.
- W1452946734 hasLocation W14529467343 @default.
- W1452946734 hasLocation W14529467344 @default.
- W1452946734 hasOpenAccess W1452946734 @default.
- W1452946734 hasPrimaryLocation W14529467341 @default.
- W1452946734 hasRelatedWork W2350745226 @default.
- W1452946734 hasRelatedWork W2411601854 @default.